These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24732594)

  • 21. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
    Ferrajoli A; Shanafelt TD; Ivan C; Shimizu M; Rabe KG; Nouraee N; Ikuo M; Ghosh AK; Lerner S; Rassenti LZ; Xiao L; Hu J; Reuben JM; Calin S; You MJ; Manning JT; Wierda WG; Estrov Z; O'Brien S; Kipps TJ; Keating MJ; Kay NE; Calin GA
    Blood; 2013 Sep; 122(11):1891-9. PubMed ID: 23821659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
    Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
    Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines.
    Lia M; Carette A; Tang H; Shen Q; Mo T; Bhagat G; Dalla-Favera R; Klein U
    Blood; 2012 Mar; 119(13):2981-90. PubMed ID: 22174151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic lymphocytic leukemia: molecular genetics and animal models.
    Pekarsky Y; Calin GA; Aqeilan R
    Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
    Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
    FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
    Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
    Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-15 and miR-16 induce apoptosis by targeting BCL2.
    Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR deregulation in CLL.
    Balatti V; Pekarky Y; Rizzotto L; Croce CM
    Adv Exp Med Biol; 2013; 792():309-25. PubMed ID: 24014303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
    Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
    Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
    Calin GA; Croce CM
    Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of miR-15a and miR-16-1 in the Pathogenesis of Chronic Lymphocytic Leukemia, and the Importance of microRNAs in Targeted Therapies.
    Calva-Lopez A; Tirado CA
    J Assoc Genet Technol; 2018; 44(3):84-87. PubMed ID: 30208014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes.
    Mraz M; Pospisilova S; Malinova K; Slapak I; Mayer J
    Leuk Lymphoma; 2009 Mar; 50(3):506-9. PubMed ID: 19347736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.
    Kasar S; Salerno E; Yuan Y; Underbayev C; Vollenweider D; Laurindo MF; Fernandes H; Bonci D; Addario A; Mazzella F; Raveche E
    Genes Immun; 2012 Feb; 13(2):109-19. PubMed ID: 21881595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-15b/16-2 deletion promotes B-cell malignancies.
    Lovat F; Fassan M; Gasparini P; Rizzotto L; Cascione L; Pizzi M; Vicentini C; Balatti V; Palmieri D; Costinean S; Croce CM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11636-41. PubMed ID: 26324892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-15a and miR-16-1 cluster functions in human leukemia.
    Calin GA; Cimmino A; Fabbri M; Ferracin M; Wojcik SE; Shimizu M; Taccioli C; Zanesi N; Garzon R; Aqeilan RI; Alder H; Volinia S; Rassenti L; Liu X; Liu CG; Kipps TJ; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5166-71. PubMed ID: 18362358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.
    Raveche ES; Salerno E; Scaglione BJ; Manohar V; Abbasi F; Lin YC; Fredrickson T; Landgraf P; Ramachandra S; Huppi K; Toro JR; Zenger VE; Metcalf RA; Marti GE
    Blood; 2007 Jun; 109(12):5079-86. PubMed ID: 17351108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
    Nana-Sinkam SP; Croce CM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.